Monogram Orthopedics Inc. (MGRM): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Monogram Technologies Inc (MGRM)

Monogram Technologies (MGRM) is developing robotic joint systems, generating profit through the sale of software and consumables. The company's P/S ratio on the GURU.Markets daily chart reflects the valuation trend, where 299.60 describes the current status of the metric. Growth potential is linked to 3D printing implants based on AI models, although the current R&D stage creates high costs in the absence of operating leverage.

Price-to-Revenue Ratio: Monogram Orthopedics (MGRM) for 03/16/2024 - 03/21/2025

Metric breakdowns and analytics for Monogram Technologies Inc (MGRM)

- stock quotes and analyst forecast:
Summary company analytics:monogramorthopedics.com
Mass-produced product of monogramorthopedics.com

The P/S multiple, equal to 299.60, compares the market capitalization of Monogram Technologies (MGRM) to its annual revenue, allowing for an assessment of the value of each dollar of sales. The price-to-sales ratio dynamics serve as a stress-test tool for asset overheating, which is critical for the robotic surgery ecosystem, where high switching costs ensure a stable cash flow and justify a premium business valuation.

Competitors of Monogram Technologies

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue masimo.com|STVN (Stevanato Group) - P/S Multiple|Price to Sales Teleflex Inc. TFX|Price-to-Revenue Ratio Merit Medical Systems Inc (MMSI)|Nobel Biocare - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (dentsplysirona.com)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Inc ATRC|STAAR Surgical Corp (STAA) - Price-to-Revenue Ratio|Market Cap to Revenue Niagen|Price-to-Revenue Ratio ZimVie Inc.|Price to Sales angiodynamics.com ANGO|Price-to-Revenue Ratio Cerus (CERS)|Alpha Teknova - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Sharps Technology STSS|InfuSystem (INFU) - Price to Sales|Utah Medical Products - P/S Multiple|Price-to-Revenue Multiple KORU Medical Systems (KRMD)|Nyxoah (NYXH) - Price-to-Revenue Ratio|Microbot Medical, Inc. - Market Capitalization-to-Revenue Ratio|PDEX (Pro-Dex Corp) - P/S Multiple|P/S Multiple Zentek Corp|Price-to-Revenue Ratio Elutia Inc. (ELUT)|Market Cap to Revenue milestonescientific.com MLSS|NEXGEL - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio RVP|HBIO: Market Cap to Revenue|Femasys Corporation - Market Cap to Sales Volume|MHUA: P/S Multiple|Price to Sales Predictive Oncology Inc. (POAI)|CJMB (Callan JMB Inc.) - P/S Multiple|Market Cap to Revenue Atrion Corp. (ATRI)|P/S Multiple NURO